Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study

OBJECTIVE: Hypogonadism is common in male patients with adrenocortical carcinoma (ACC) who are under treatment with mitotane, but the phenomenon is underestimated, and its prevalence has been poorly studied. This single-center retrospective longitudinal study was undertaken to assess the frequency o...

Descripción completa

Detalles Bibliográficos
Autores principales: Delbarba, Andrea, Cosentini, Deborah, Facondo, Paolo, Laganà, Marta, Pezzaioli, Letizia Chiara, Cremaschi, Valentina, Alberti, Andrea, Grisanti, Salvatore, Cappelli, Carlo, Ferlin, Alberto, Berruti, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108714/
https://www.ncbi.nlm.nih.gov/pubmed/37077359
http://dx.doi.org/10.3389/fendo.2023.1128061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108714/
https://www.ncbi.nlm.nih.gov/pubmed/37077359
http://dx.doi.org/10.3389/fendo.2023.1128061

Ejemplares similares